Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 663, pseudogene (RN7SL663P)

Target: RN7SL663P
Molecular classification: Other (Pseudogene), Non-coding RNA (homology to 7SL RNA)

Overview

RN7SL663P is a human pseudogene that resembles the 7SL RNA gene responsible for encoding the RNA component of the signal recognition particle (SRP)[6][7]. SRP 7SL RNA plays a central architectural and enzymatic role in SRP assembly, mediating protein targeting to the endoplasmic reticulum[1][5]. However, RN7SL663P is a non-functional, truncated remnant likely formed via the reverse transcription of 7SL RNA and its subsequent integration into genomic DNA; it does not encode a protein or functional RNA and is not considered a therapeutic target[7].

Other names: RN7SL663P

Mechanism of action

None relevant; as a pseudogene, it does not encode a targetable molecule for drugs.

Biological functions

None (No known biological function; pseudogenes generally lack protein-coding or canonical RNA function; functional counterparts such as the 7SL RNA gene are involved in SRP assembly, but this pseudogene does not perform that role)

Disease associations

None confirmed for RN7SL663P. Some pseudogenes, through noncoding RNA activities, can modulate gene expression or act as microRNA sponges, which may influence cancer or other diseases[4], but there is no data to support a specific disease role for RN7SL663P.

Safety considerations

None; as a non-functional pseudogene, there are no known safety concerns or therapeutic challenges associated with targeting RN7SL663P.

Interacting drugs

None documented. There are no drugs known to interact with RN7SL663P.

Biomarkers

None documented. RN7SL663P is not used as a biomarker for any disease or therapy.

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 663, pseudogene (RN7SL663P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 663, pseudogene (RN7SL663P).

Explore the full profile